Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE.
Acadia Healthcare Company (ACHC) is back in focus after recent data showed declining earnings per share and a sharp drop in free cash flow margin, even as revenue and admissions continued to grow.
Admissions reached 52,170 in the latest quarter, with average year-on-year growth of 3.1% over the last two years. Over the same period, earnings per share declined 6.1% annually, and free cash flow margin fell 18.9 percentage points over five years.
See our latest analysis for Acadia Healthcare Company.
At a share price of US$22.91, Acadia has a 90 day share price return of 58.0% and a year to date share price return of 60.3%. Its 1 year total shareholder return of a 23.9% loss and 5 year total shareholder return of a 59.7% loss point to longer term underperformance, suggesting recent momentum may reflect shifting expectations about its earnings and cash flow profile rather than a sustained track record of value creation.
If you are weighing Acadia’s recent rebound against other opportunities in healthcare, it may be worth scanning for companies using AI in care delivery and operations through the 34 healthcare AI stocks
With Acadia now trading close to its analyst price target after a sharp 90 day rebound, but still carrying multi year shareholder losses and weak cash generation, is there real upside left here or is the market already pricing in future growth?
According to the most followed narrative, Acadia Healthcare’s fair value is set at $11.94, well below the last close of $22.91, which frames the recent rebound as rich against that benchmark.
Behavioral health has long been one of the most under-resourced areas of the U.S. healthcare system. That is changing, slowly, unevenly, but decisively. Acadia Healthcare (NASDAQ: ACHC), one of the largest pure play behavioral health operators, sits at the center of that shift.
Want to see how an under supplied segment, execution risks, and integrated care assumptions all feed into that fair value? The narrative leans heavily on persistent demand, policy support, and a specific view on how much scale can translate into sustainable margins. The full story connects those moving parts directly to the cash flow path behind $11.94.
Result: Fair Value of $11.94 (OVERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, this story can break if execution stumbles, for example through tighter regulation or sustained margin pressure that keeps cash generation weak despite steady admissions and revenue.
Find out about the key risks to this Acadia Healthcare Company narrative.
The most popular narrative pegs fair value at US$11.94 and calls Acadia overvalued, but our DCF model points in the opposite direction. On that view, the shares trade about 80.3% below an estimated fair value of US$116.46. This raises a simple question: which story do you trust more, the cash flows or the crowd?
Look into how the SWS DCF model arrives at its fair value.
ACHC Discounted Cash Flow as at Mar 2026
With such mixed signals on valuation, sentiment and fundamentals, it makes sense to move quickly and test the assumptions that matter most to you. A good place to start is by weighing the 3 key rewards and 2 important warning signs
If Acadia has sharpened your focus on quality and risk, do not stop here. Broaden your watchlist with ideas that match your own return and resilience goals.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ACHC.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com